Angiogenic factor secretion by melanocytes associated with pigmentation leve

The decreased vision loss that accompanies age-related macular degeneration (AMD) is associated with abnormal blood vessel growth in the eye. Frequencies of AMD development are different among racial backgrounds, with occurrence of AMD highest among individuals of mixed European decent. Furthermore, other diseases associated with dysfunctional neovascularization occur at different frequencies depending on racial background, suggesting a connection between pigmentation and susceptibility to angiogenic disease.

In this issue of the Journal of Clinical Investigation, Irit Adini and colleagues at the Harvard Medical School determined that melanocytes from light-skinned humans and albino mice secrete high levels of fibromodulin and that fibromodulin promotes angiogenesis.

In a companion commentary, Christopher Kontos of Duke University discusses the potential for fibromodulin to be both a useful biomarker and a therapeutic target for diseases associated with increased vascularization.

More information: Melanocyte-secreted fibromodulin promotes an angiogenic microenvironment, J Clin Invest. DOI: 10.1172/JCI69404
More than skin deep: connecting melanocyte pigmentation and angiogenic diseases, J Clin Invest. 2014;124(1):76–79. DOI: 10.1172/JCI73559

add to favorites email to friend print save as pdf

Related Stories

Findings support link between hsCRP, macular degeneration

Feb 08, 2013

(HealthDay)—Pooled results from five cohorts confirm that high levels of high-sensitivity C-reactive protein (hsCRP) correlate with increased future risk of age-related macular degeneration (AMD), according ...

Recommended for you

Glassy protein solution may cause eyesight deterioration

Nov 26, 2014

Long-sightedness caused by age could be due to proteins in the lens of the eye that are converted from a fluid solution to a solid, glassy state. This has been shown in a study by researchers from institutions ...

HIV/AIDS drugs could be repurposed to treat AMD

Nov 20, 2014

A landmark study published today in the journal Science by an international group of scientists, led by the laboratory of Dr. Jayakrishna Ambati, professor & vice chair of the Department of Ophthalmology & Visu ...

New laser therapy helps slow macular degeneration

Nov 19, 2014

(Medical Xpress)—A new, low impact low energy laser treatment for patients with early age-related macular degeneration (AMD) has produced positive results by reducing indicators of the disease.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.